Microorganisms isolated from the bile of the patients who have undergone cholecystectomy and their antibiotic resistance pattern: multicenter prospective study.


Journal

International microbiology : the official journal of the Spanish Society for Microbiology
ISSN: 1618-1905
Titre abrégé: Int Microbiol
Pays: Switzerland
ID NLM: 9816585

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 17 02 2022
accepted: 23 05 2022
revised: 15 05 2022
pubmed: 3 7 2022
medline: 5 10 2022
entrez: 2 7 2022
Statut: ppublish

Résumé

Gallbladder and biliary tract infections are diseases with high mortality rates if they are not treated properly. Microbiological evaluation of perioperatively collected samples both ensures proper treatment of patients and guides empirical treatment due to the determination of microorganism susceptibility. This study aimed to isolate the microorganisms in bile cultures from patients who underwent cholecystectomy and to determine sensitivity results of these microorganisms. This study was a multi-center and prospective design, included 360 patients, and was performed between 2019 and 2020. Culture results of bile taken during cholecystectomy were evaluated. Bacterial growth was found in the bile cultures of 84 out of 360 (23.3%) patients. Patients were divided into two groups according to whether they had risk factors for resistant microorganisms or not. While Escherichia coli (n = 11, 13%), Enterococcus spp. (n = 8, 9.5%), and Enterobacter spp. (n = 4, 4.7%) were detected most frequently in patients without risk. Staphylococcus spp. (n = 17, 20.2%), Enterococcus spp. (n = 16, 19%), and E. coli (n = 8, 9.5%) were the most frequently found microorganism at-risk patients. In multivariate analysis, bile culture positivity was found higher in patients who had history of biliary disease (p = 0.004), operation performed concurrently with a cholecystectomy (p = 0.035), and high rate of polymorphonuclear leukocytes (PNL) in total leukocyte count (p = 0.001). Our study shows that when starting empirical antibiotic treatment for bile ducts, whether patients are at risk for the development of resistant bacterial infection should be evaluated after which antibiotic selection should be made accordingly.

Sections du résumé

BACKGROUND BACKGROUND
Gallbladder and biliary tract infections are diseases with high mortality rates if they are not treated properly. Microbiological evaluation of perioperatively collected samples both ensures proper treatment of patients and guides empirical treatment due to the determination of microorganism susceptibility.
AIMS OBJECTIVE
This study aimed to isolate the microorganisms in bile cultures from patients who underwent cholecystectomy and to determine sensitivity results of these microorganisms.
METHODS METHODS
This study was a multi-center and prospective design, included 360 patients, and was performed between 2019 and 2020. Culture results of bile taken during cholecystectomy were evaluated.
RESULTS RESULTS
Bacterial growth was found in the bile cultures of 84 out of 360 (23.3%) patients. Patients were divided into two groups according to whether they had risk factors for resistant microorganisms or not. While Escherichia coli (n = 11, 13%), Enterococcus spp. (n = 8, 9.5%), and Enterobacter spp. (n = 4, 4.7%) were detected most frequently in patients without risk. Staphylococcus spp. (n = 17, 20.2%), Enterococcus spp. (n = 16, 19%), and E. coli (n = 8, 9.5%) were the most frequently found microorganism at-risk patients. In multivariate analysis, bile culture positivity was found higher in patients who had history of biliary disease (p = 0.004), operation performed concurrently with a cholecystectomy (p = 0.035), and high rate of polymorphonuclear leukocytes (PNL) in total leukocyte count (p = 0.001).
CONCLUSIONS CONCLUSIONS
Our study shows that when starting empirical antibiotic treatment for bile ducts, whether patients are at risk for the development of resistant bacterial infection should be evaluated after which antibiotic selection should be made accordingly.

Identifiants

pubmed: 35779154
doi: 10.1007/s10123-022-00251-y
pii: 10.1007/s10123-022-00251-y
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

759-767

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

Abeysuriya V, Deen KI, Wijesuriya T et al (2008) Microbiology of gallbladder bile in uncomplicated symptomatic cholelithiasis. Hepatobiliary Pancreat Dis Int 7(6):633–637
pubmed: 19073410
Adrian AI, Ian JB (2002) Acute cholecystitis. BMJ :21; 325(7365): 639–643. https://doi.org/10.1136/bmj.325.7365.639 .
Capoor MR, Nair Rajni D et al (2008) Microflora of bile aspirates in patients with acute cholecystitis with or without cholelithiasis: a tropical experience. Braz J Infect Dis. 12(3):222–5. https://doi.org/10.1590/S1413-86702008000300012
doi: 10.1590/S1413-86702008000300012 pubmed: 18839486
Chow AW, Evans GA, Nathens AB et al (2010) Canadian practice guidelines for surgical intra-abdominal infections. Can J Infect Dis Med Microbiol 21(1):11–37
doi: 10.1155/2010/580340
Clinical practice guidelines for antimicrobial prophylaxis in surgery. ASHP therapeutic guidelines. https://www.ashp.org/surgical-guidelines
Coccolini F, Sartelli M, Catena F, et al, CIAO and CIAOW study groups. Antibiotic resistance pattern and clinical out-comes in acute cholecystitis: 567 consecutive worldwide patientsin a prospective cohort study. Int J Surg. 2015;21:32–7. https://doi.org/10.1016/j.ijsu.2015.07.013 .
Darkahi B, Sandblom G, Liljeholm H et al (2014) Biliary microflora in patients undergoing cholecystectomy. Surg Infect 15(3):262–265. https://doi.org/10.1089/sur.2012.125
doi: 10.1089/sur.2012.125
Dyrhovden R, Øvrebø KK, Nordahl MV et al (2020) Bacteria and fungi in acute cholecystitis. A prospective study comparing next generation sequencing to culture. J Infect. 80(1):16–23. https://doi.org/10.1016/j.jinf.2019.09.015
doi: 10.1016/j.jinf.2019.09.015 pubmed: 31586461
European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2018) European Committee on Antimicrobial Susceptibility Testing breakpoint tables for interpretation of MICs and zone diameters, version 8.1. http://www.eucast.org
Galili O, Eldar S, Matter I et al (2008) The effect of bactibilia on the course and outcome of laparoscopic cholecystectomy. Eur J Clin Microbiol Infect Dis 27(9):797–803. https://doi.org/10.1007/s10096-008-0504-8
doi: 10.1007/s10096-008-0504-8 pubmed: 18369670
Gomi H, Solomkin JS, Schlossberg D et al (2008) Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 25(1):3–16. https://doi.org/10.1002/jhbp.518
doi: 10.1002/jhbp.518
Gupta E, Chakravarti A (2008) Viral infections of the biliary tract. Saudi J Gastroenterol 14(3):158–160. https://doi.org/10.4103/1319-3767.41740
doi: 10.4103/1319-3767.41740 pubmed: 19568530 pmcid: 2702917
Iribar BP, Peña EA, Rubio- PI (2017) Not just complicated cholecystitis—beware of risk factors! Surg Infect Case Reports 2(1):98–100. https://doi.org/10.1089/crsi.2017.0029
doi: 10.1089/crsi.2017.0029
Jaafar G, Hammarqvist F, Enochsson L et al (2017) Patient-related risk factors for postoperative infection after cholecystectomy. World J Surg 41(9):2240–2244. https://doi.org/10.1007/s00268-017-4029-0
doi: 10.1007/s00268-017-4029-0 pubmed: 28634841 pmcid: 5544799
Katyal A, Bala K, Bansal A et al (2017) Clinico-microbiological analysis of bactibilia isolates in patients of cholecystectomy. Int J Res Med Sci. 5(9):4030–4035. https://doi.org/10.18203/2320-6012.ijrms20173977
doi: 10.18203/2320-6012.ijrms20173977
Magiorakos AP, Srinivasan A, Carey RB et al (2012 Mar) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281
doi: 10.1111/j.1469-0691.2011.03570.x
Mahafzah AM, Daradkeh SS (2009) Profile and predictors of bile infection in patients undergoing laparoscopic cholecystectomy. Saudi Med J 30(8):1044–1048
pubmed: 19668885
Maseda E, Maggi G, Gomez-Gil R et al (2013) Prevalence of and risk factors for biliary carriage of bacteria showing worrisome and unexpected resistance traits. J Clin Microbiol 51(2):518–521. https://doi.org/10.1128/JCM.02469-12
doi: 10.1128/JCM.02469-12 pubmed: 23196362 pmcid: 3553897
Mustafa M, Menon J, Rahman MDS et al (2014) Acute Biliary tract infections, diagnostic criteria and treatment. Int J Pharm Sci Invent 3(10):58–62. https://doi.org/10.1016/j.jviscsurg.2019.05.007
doi: 10.1016/j.jviscsurg.2019.05.007
Park JW, Lee JK, Lee KT et al (2014) How to interpret the bile culture results of patients with biliary tract infections. Clin Res Hepatol Gastroenterol 38(3):300–309. https://doi.org/10.1016/j.clinre.2014.02.005
doi: 10.1016/j.clinre.2014.02.005 pubmed: 24674840
Potts JR (1990) What are the indications for cholecystectomy? Cleve Clin J Med 57(1):40–47. https://doi.org/10.3949/ccjm.57.1.40
doi: 10.3949/ccjm.57.1.40 pubmed: 2407388
Yun SP, Seo H-II (2018) Clinical aspects of bile culture in patients undergoing laparoscopic cholecystectomy. Med (Baltimore) 97(26):e11234. https://doi.org/10.1097/MD.0000000000011234
doi: 10.1097/MD.0000000000011234

Auteurs

Derya Ozturk-Engin (D)

Department of Infectious Diseases and Clinical Microbiology, Health Sciences University, Fatih Sultan Mehmet Training and Research Hospital, Atasehir, Istanbul, Turkey. derya.ozturkengin@sbu.edu.tr.

Canan Agalar (C)

Department of Infectious Diseases and Clinical Microbiology, Health Sciences University, Fatih Sultan Mehmet Training and Research Hospital, Atasehir, Istanbul, Turkey.

Yasemin Cag (Y)

Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Istanbul Medeniyet University, Göztepe Training and Research Hospital, Kadikoy, Istanbul, Turkey.

Fatma Kesmez Can (FK)

Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ataturk University, Yakutiye, Erzurum, Turkey.

Ilker Inanc Balkan (II)

Department of Infectious Diseases and Clinical Microbiology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Fatih, Istanbul, Turkey.

Oguz Karabay (O)

Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Sakarya University, Serdivan, Sakarya, Turkey.

Seniha Senbayrak (S)

Department of Infectious Diseases and Clinical Microbiology, Health Sciences University, Haydarpasa Numune Training and Research Hospital, Uskudar, Istanbul, Turkey.

Busra Meral Çetinkaya (BM)

Department of Infectious Diseases and Clinical Microbiology, Health Sciences University, Fatih Sultan Mehmet Training and Research Hospital, Atasehir, Istanbul, Turkey.

Mehmet Timuçin Aydın (MT)

Department of General Surgery, Health Sciences University, Fatih Sultan Mehmet Training and Research Hospital, Atasehir, Istanbul, Turkey.

Kadir Tomas (K)

Department of General Surgery. Recep, Faculty of Medicine, Tayyip Erdogan University, Rize, Turkey.

Esra Disci (E)

Department of General Surgery, Faculty of Medicine, Ataturk University, Yakutiye, Erzurum, Turkey.

Ali Surmelioglu (A)

Department of General Surgery, Health Sciences University, Haydarpasa Numune Training and Research Hospital, Uskudar, Istanbul, Turkey.

Orhan Alimoglu (O)

Department of General Surgery, Faculty of Medicine, Istanbul Medeniyet University, Göztepe Training and Research Hospital, Kadikoy, Istanbul, Turkey.

Ozgur Ekinci (O)

Department of General Surgery, Faculty of Medicine, Istanbul Medeniyet University, Göztepe Training and Research Hospital, Kadikoy, Istanbul, Turkey.

Emrah Akın (E)

Department of General Surgery, Faculty of Medicine, Sakarya University, Serdivan/Sakarya, Turkey.

Mehmet Köroglu (M)

Department of Medical Microbiology, Faculty of Medicine Serdivan/Sakarya, Sakarya University, Serdivan/Sakarya, Turkey.

Mehmet Velidedeoglu (M)

Department of General Surgery, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Fatih, Istanbul, Turkey.

Handan Ankaralı (H)

Department of Biostatistics, Faculty of Medicine, Istanbul Medeniyet University, Göztepe Training and Research Hospital, Kadikoy, Istanbul, Turkey.

Esra Kocoglu (E)

Department of Medical Microbiology, Faculty of Medicine, Istanbul Medeniyet University, Göztepe Training and Research Hospital, Istanbul, Turkey.

Mirkhaliq Javadov (M)

Department of General Surgery, Faculty of Medicine, Yeditepe University, Istanbul, Turkey.

Berrin Papilla-Kundaktepe (B)

Department of General Surgery, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Fatih, Istanbul, Turkey.

Naz Oguzoglu (N)

Department of Medical Microbiology, Health Sciences University, Haydarpasa Numune Training and Research Hospital, Uskudar, Istanbul, Turkey.

Erkan Ozmen (E)

Department of Medical Microbiology, Faculty of Medicine, Ataturk University, Yakutiye/Erzurum, Turkey.

Ramazan Donmez (R)

Department of General Surgery, Faculty of Medicine, Yeditepe University, Istanbul, Turkey.

Ertunç Mega (E)

Department of Surgery, Health Sciences University, Fatih Sultan Mehmet Training and Research Hospital, Atasehir, Istanbul, Turkey.

Sebahat Aksaray (S)

Department of Medical Microbiology, Health Sciences University, Haydarpasa Numune Training and Research Hospital, Uskudar, Istanbul, Turkey.

Fatih Agalar (F)

Department of General Surgery, Faculty of Medicine, Yeditepe University, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH